HRID223586

反应详情

EQUATION

反应方程式

REACTANTS

反应物

结构：CC(C)C[C@H]1NC(=O)[C@@H](NC(=O)c2ncccc2O)[C@@H](C)OC(=O)[C@H](c2ccccc2)N(C)C(=O)[C@H](C)NC(=O)C([C@@H](C)C(C)C)N(C)C(=O)CN(C)C(=O)[C@H]2C[C@@H](O)CN2C1=O

HCID196972

未命名化合物

结构：CC(C)CC1NC(=O)C(NC(=O)c2ncccc2O)C(C)OC(=O)C(c2ccccc2)N(C)C(=O)C(C)NC(=O)C(C(C)C(C)C)N(C)C(=O)CN(C)C(=O)C2CC(O)CN2C1=O

HCID417256

未命名化合物

$结构：C[C@@H]1C/C=C2\SC[C@@H](NC(=O)c3coc(n3)C[C@H](O)C[C@H](O)/C=C\C=C/CNC2=O)C(=O)O1$

HCID6441064

Griseoviridin

C22H27N3O7S

2 次

PRODUCTS

生成物

HCID420843

未命名化合物

PROCEDURE

实验过程

In addition the identity of neoviridogrisein IV with viridogrisein was further confirmed by IR, UV, NMR and mass spectrometry, thin layer chromatography, hydrolysate analysis and antimicrobial spectrometry. On the other hand, the griseoviridin preparation obtained in Example 5 was crystallized in warm methanol to yield needle crystals. Then a part of the needle crystals were compared and identified with an authentic preparation of griseoviridin by IR, UV, NMR and mass spectrometry, thin layer chromatography, elementary analysis and other physico-chemical properties.

WORKUP

后处理

customobtained in Example 5
customwas crystallized in warm methanol
customto yield needle crystals